Transmedics Group, Inc.
Could not find a ticker for this position, may be a filing error
A medical technology company that makes the Organ Care System, a portable device that keeps donor hearts, lungs, and livers warm, beating, and functioning outside the body during transport—a shift from the old method of packing organs on ice. Founded in 1998 by cardiac surgeon Dr. Waleed Hassanein, the company's name blends "transplant" and "medics." Its machines let transplant teams assess and preserve organs in a near-living state while they travel to recipients.
1.5% convertible senior notes due June 1, 2028
Bought 8.8K
Granted 2.9K
Granted 2.9K
Sold 3.0K
Granted 22.2K · Sold 9.6K
Granted 15.4K
Granted 11.5K · Sold 8.6K
Granted 7.2K · Sold 8.5K
Granted 3.0K · Sold 3.9K
Granted 11.1K
Granted 2.9K
Granted 7.1K · Sold 4.1K
Granted 2.9K · Sold 1.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Hassanein Waleed HPresident & CEO, Director · 1 transaction | +1.8% | 616.4K | — | 8.8K | — |
| Kania EdwinDirector · 1 transaction | — | 309.9K | 2.9K | — | — |
| Tobin James RDirector · 1 transaction | +1.6% | 180.1K | 2.9K | — | — |
| Corcoran NicholasSee remarks · 2 transactions | -11.7% | 29.8K | — | — | 3.0K |
| Gunderson Thomas J.Director · 3 transactions | — | 16.6K | 22.2K | — | 9.6K |
| Forsyth Matthew S.See Remarks · 1 transaction | — | 15.4K | 15.4K | — | — |
| Weill DavidDirector · 5 transactions | +24.1% | 15.1K | 11.5K | — | 8.6K |
| Hernandez GerardoChief Financial Officer · 6 transactions | -8.1% | 14.7K | 7.2K | — | 8.5K |
| Ranganath Anil P.See remarks · 3 transactions | -6.2% | 13.1K | 3.0K | — | 3.9K |
| Cecere GiovanniChief Commercial Officer · 1 transaction | — | 8.0K | 11.1K | — | — |
| Raines MerileeDirector · 1 transaction | +72% | 7.0K | 2.9K | — | — |
| Basile Edward MDirector · 3 transactions | +102% | 5.8K | 7.1K | — | 4.1K |
| Lovell StephanieDirector · 2 transactions | +42.6% | 5.8K | 2.9K | — | 1.2K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -30.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.